Last year we closed the year at $.18. While intra-year we certainly saw more, I don't know anyone who'd complain if their stock portfolio were up the better than 275% that we've experienced this year.
While I believe we could do much better than that, it's still nothing to complain about.
Our success in the next year will be predicated on establishing sales for at least one product, and hopefully two products by the end of the year. I don't believe the volume of sales will be that important, what's important is that they happen.
In 2 to 4 years from now I've got to believe that sales of products that OWCP developed will be in the billions, and while these sales will be made through a variety of companies all over the world, OWCP should be earning somewhere in the hundreds of millions meaning that shareholders should see stock prices that reflect over $1 per share, and perhaps as much as $3. For a fast growing cannabis based biotech, I believe that 30 would be a rather conservative P/E ratio, so I'm speaking of a share price of $30 or more. Foe those who hold on to their shares, most of us ought to be millionaires or getting very close to it by then. Of course this is totally based on the fact that our products work, but that will become established later next year.
Gary
News 
Market Data 
Discover 
